Putnam Investments »

Vaxcyte shares owned by Putnam Investments

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Putnam Investments from 13F filings

Historical chart of Putnam Investments investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Putnam Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Putnam Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $14M 227k 62.80
2023-09-30 $5.4M 106k 50.98
2023-06-30 $4.5M 91k 49.94

More positions owned by Putnam Investments

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Nvidia Corp Common Stock (NVDA)
Exxon Mobil Corp Common Stock (XOM)
Oracle Corp Common Stock (ORCL)
Walmart Common Stock (WMT)
Bank Of America Corp Common Stock (BAC)
Alphabet Common Stock (GOOG)
Pultegroup Common Stock (PHM)
Regeneron Pharmaceuticals Common Stock (REGN)
Meta Platforms Common Stock (META)
Unitedhealth Group Common Stock (UNH)
Mckesson Corp Common Stock (MCK)
Merck & Co Common Stock (MRK)

View all positions for Putnam Investments

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
BlackRock
T. Rowe Price Investment Management
Wellington Management Company
State Street Corporation
D. E. Shaw & Co
Paradigm Biocapital Advisors
Westfield Capital Management Company
Kynam Capital Management
Deep Track Capital
Geode Capital Management
Jpmorgan Chase & Co

View all funds holding Vaxcyte